ZBIO Stock Analysis: Buy, Sell, or Hold?
ZBIO - Zenas BioPharma, Inc. Common Stock
$28.78
0.90 (3.23%)
▲
5d:
+3.97%
30d:
+62.05%
90d:
+36.79%
BUY
HIGH Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
26d
Get Alerted When ZBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ZBIO shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
✅ BUY SIGNAL: ZBIO shows strong fundamentals and good volume confirmation. Solid entry point despite extended pricing.
In-depth Analysis How we analyze
Valuation Analysis: ZBIO is currently trading at $28.78, which is considered extended relative to its 30-day fair value range of $18.77 to $27.49.
Technical Outlook: Technically, ZBIO is showing sideways momentum. Immediate support is located at $25.13, while resistance sits at $30.00. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: ZBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.12 (+46.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZBIO is showing sideways momentum. Immediate support is located at $25.13, while resistance sits at $30.00. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: ZBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.12 (+46.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.77 -
$27.49
Company Quality Score
61/100
(BUY)
Options IV Signal
5th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
75.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 5th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 46.4% below Wall St target ($42.12)
Trading Range Analysis
30-Day Trading Range
$18.77 -
$27.49
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.74
(13.0%)
Support & Resistance Levels
Support Level
$25.13
Resistance Level
$30.00
Current Trend
Sideways
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.71
Wall Street Target
$42.13
(+46.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 14, 2026 8:09 PM ET
Data refreshes hourly during market hours. Next update: 9:09 PM
Data refreshes hourly during market hours. Next update: 9:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBIO showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Fairmount Funds Manageme…
BUY
150000 shares
2026-03-31
Hongbo Lu
BUY
3768 shares
2026-03-31
Patricia L Allen
BUY
4160 shares
2026-02-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
Advanced ZBIO Option Strategies
Professional options setups generated by AI based on today's ZBIO price and gamma walls.
